Integral Systems, Inc. (Integral) (NASDAQ:ISYS) announced today that it has purchased the intellectual property and other assets relating to the satID product line from U.K.-based QinetiQ Group PLC.
Founded in 2001, Integral Molecular is a biotechnology company and industry leader in developing therapeutics targeting membrane proteins. As a result of that, Integral has over two decades of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results